US Patent Issued to CONNECT BIOPHARMA HONGKONG on April 14 for "Antibody for binding to interleukin 4 receptor" (Chinese, Canadian, American Inventors)

ALEXANDRIA, Va., April 15 -- United States Patent no. 12,600,771, issued on April 14, was assigned to CONNECT BIOPHARMA HONGKONG Ltd. (Kowloon, Hong Kong).

"Antibody for binding to interleukin 4 receptor" was invented by Wei Zheng (San Diego), Wubin Pan (Richmond, Canada), Xin Yang (Taicang, China), Yang Chen (Taicang, China), Limin Zhang (Taicang, China) and Jie Jiang (Taicang, China).

According to the abstract* released by the U.S. Patent & Trademark Office: "Disclosed is an antibody capable of binding to the interleukin 4 (IL-4) receptor (IL-4). Also disclosed are a nucleic acid sequence encoding the antibody, a vector including the nucleic acid sequence, and a host cell transformed or transfected with the vector. Provided are a method...